Chimerix Announces Three Abstracts to be Presented at the 2014 World Transplant Congress DURHAM, N.C., July 8, 2014 (GLOBE NEWSWIRE) — Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical...
Awarepoint awareAssets version 3.0 Now Available Healthcare RTLS leader announces updates to asset tracking software, enhancing resource management, efficiency and compliance SAN DIEGO – July 8, 2014 – Awarepoint Corporation, the largest real-time location system...
Concert Pharmaceuticals Announces FDA Lifts Partial Clinical Hold for CTP-354, A Novel Drug Candidate for Spasticity LEXINGTON, Mass.–(July 16, 2014)– Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that the FDA has provided notification that...
CareDx Announces Pricing of its IPO and Completion of its First Day of Trading Brisbane, CA – July 17, 2014 – CareDx, Inc. (NASDAQ: CDNA) announced the pricing of its initial public offering of 4,000,000 shares of its common stock at a price to the public...
Durata Therapeutics Announces the U.S. Launch of DALVANCE™ CHICAGO, July 18, 2014 (GLOBE NEWSWIRE) — Durata Therapeutics, Inc. (Nasdaq:DRTX) announced today that Dalvance (dalbavancin) for injection is now available for use to treat adult patients with acute...
Recent Comments